Abstract
Meeting abstracts Antigen-specific DNA vaccine immunotherapy is an attractive approach for the treatment of cancer since it has the potency to specifically eradicate systemic tumors without damaging the normal cells. However, DNA vaccine shows insufficient immune response for antigen presenting
Highlights
Antigen-specific DNA vaccine immunotherapy is an attractive approach for the treatment of cancer since it has the potency to eradicate systemic tumors without damaging the normal cells
Cryoablation therapy stimulates the antigenspecific T cell immune responses generated by therapeutic HPV DNA vaccine
The mice were divided into four groups: group 1 received no treatment after the E7-expressing TC-1 tumor challenge, group 2 was treated with cryoablation therapy, group 3 was immunized with the CRT/E7 DNA vaccine, and group 4 was both immunized and received cryoablation therapy
Summary
Antigen-specific DNA vaccine immunotherapy is an attractive approach for the treatment of cancer since it has the potency to eradicate systemic tumors without damaging the normal cells. Cryoablation therapy stimulates the antigenspecific T cell immune responses generated by therapeutic HPV DNA vaccine From 30th Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2015) National Harbor, MD, USA.
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
